Suppr超能文献

3-巯基吡啶甲酸对肝脏磷酸烯醇式丙酮酸羧激酶(GTP)的抑制机制。

Mechanism of 3-mercaptopicolinic acid inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP).

作者信息

Jomain-Baum M, Schramm V L, Hanson R W

出版信息

J Biol Chem. 1976 Jan 10;251(1):37-44.

PMID:1244353
Abstract

The hypoglycemic agent 3-mercaptopicolinic acid inhibits gluconeogenesis from lactate by isolated, perfused livers from fasted rats and guinea pigs. A 3-mercaptopicolinate concentration of 50 muM caused a sharp decrease in glucose synthesis, with virtually complete inhibition at 100 muM. This inhibitory effect was reversed completely when 3-mercaptopicolinate was removed and the rate of glucose synthesis returned to normal values within 2 min. Oxygen consumption was not altered, even at the highest concentration of inhibitor. Gluconeogenesis from glycerol by guinea pig liver was blocked completely by 100 muM 3-mercaptopicolinate but was inhibited only partially in rat liver. After removal of the inhibitor glucose synthesis returned to levels higher than noted before the addition of this compound. The formation of P-enolpyruvate bu isolated guinea pig liver mitochondria metabolizing alpha-ketoglutarate (State 3) was inhibited markedly by 3-mercaptopicolinate, but malate conversion to P-enolpyruvate was considerably less sensitive. Kinetic studies with purified P-enolpyruvate carboxykinase from rat liver cytosol indicate that 3-mercaptopicolinate is a noncompetitive inhibitor with respect to both oxalacetate and MnGTP2-, and that simulataeous saturation with both substrates does not diminish this inhibition. The inhibitory effects of 3-mercaptopicolinate occur primarily by decreasing the rate of product formation while having relatively minor effects on the apparent Michaelis constants for substrates. Inhibition constants for slope and intercept effects ranged from 3 to 9 muM 3-mercaptopicolinate, and the inhibition patterns were dependent on the concentration of free Mn2+ present. Comparison of the inhibition constants with the observed inhibition of gluconeogenesis in livers perfused with 3-mercaptopicolinate supports the contention that P-enolpyruvate carboxykinase is the site of action of this inhibitor. The possibility that 3-mercaptopicolinate inhibition occurs by binding either free or bound manganese was eliminated by determination of the dissociation constant of 0.51 mM for the manganese-3-mercaptopicolinate complex. In addition, no tightly bound, slowly exchanging metal was bound to purified enzyme protein. These results suggest that 3-mercaptopicolinate inhibits by the removal of a tightly bound, rapidly exchanging metal ion other than Mn2+.

摘要

降血糖剂3 - 巯基吡啶甲酸可抑制禁食大鼠和豚鼠的离体灌注肝脏由乳酸生成葡萄糖的糖异生过程。3 - 巯基吡啶甲酸盐浓度为50μM时可使葡萄糖合成急剧减少,在100μM时几乎完全抑制。当去除3 - 巯基吡啶甲酸盐后,这种抑制作用完全逆转,葡萄糖合成速率在2分钟内恢复到正常值。即使在抑制剂浓度最高时,氧气消耗也未改变。豚鼠肝脏由甘油生成葡萄糖的过程被100μM 3 - 巯基吡啶甲酸盐完全阻断,但在大鼠肝脏中仅被部分抑制。去除抑制剂后,葡萄糖合成恢复到高于添加该化合物之前的水平。离体豚鼠肝脏线粒体代谢α - 酮戊二酸(状态3)时生成磷酸烯醇式丙酮酸的过程被3 - 巯基吡啶甲酸盐显著抑制,但苹果酸转化为磷酸烯醇式丙酮酸的过程对其敏感性要低得多。对来自大鼠肝细胞溶胶的纯化磷酸烯醇式丙酮酸羧激酶进行的动力学研究表明,3 - 巯基吡啶甲酸盐对草酰乙酸和MnGTP2 - 均为非竞争性抑制剂,并且两种底物同时饱和时不会减弱这种抑制作用。3 - 巯基吡啶甲酸盐的抑制作用主要通过降低产物形成速率而发生,同时对底物的表观米氏常数影响相对较小。斜率和截距效应的抑制常数范围为3至9μM 3 - 巯基吡啶甲酸盐,且抑制模式取决于存在的游离Mn2 + 浓度。将抑制常数与在灌注有3 - 巯基吡啶甲酸盐的肝脏中观察到的糖异生抑制作用进行比较,支持了磷酸烯醇式丙酮酸羧激酶是该抑制剂作用位点的观点。通过测定锰 - 3 - 巯基吡啶甲酸盐复合物的解离常数为0.51 mM,排除了3 - 巯基吡啶甲酸盐通过结合游离或结合的锰而发生抑制作用的可能性。此外,纯化的酶蛋白未结合紧密结合、缓慢交换的金属。这些结果表明,3 - 巯基吡啶甲酸盐通过去除除Mn2 + 以外的紧密结合、快速交换的金属离子而发挥抑制作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验